NCT01764360
Strategies to Improve Kaposi Sarcoma (KS) Outcomes in Zimbabwe No drug interventions treatment Not Available completed NCT00339937
Studies of Human Herpesvirus 8 and Kaposi's Sarcoma in Sicily No drug interventions Not Available Not Available completed NCT01067690
Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma treatment 2 completed NCT00026793
Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions No drug interventions Not Available Not Available completed NCT00581815
Spectroscopy With Surface Coils and Decoupling No drug interventions diagnostic 1 completed NCT00380770
HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT No drug interventions treatment 4 completed NCT00686842
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma treatment 1 / 2 terminated NCT01352117
Antiretroviral Therapy (ART) Alone or With Delayed Chemo Versus ART With Immediate Chemo for Limited AIDS-related Kaposi's Sarcoma treatment 3 completed NCT03300830
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease No drug interventions Not Available Not Available recruiting NCT02201420
Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT diagnostic 2 completed NCT00001560
Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers No drug interventions Not Available Not Available completed NCT00001294
Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens No drug interventions Not Available Not Available completed NCT00444379
Anti-Retrovirals for Kaposi's Sarcoma treatment 4 completed NCT00026728
Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States No drug interventions Not Available Not Available completed NCT00006171
Effects of Potent Antiretroviral Therapy on Kaposi s Sarcoma No drug interventions Not Available Not Available completed NCT01296815
Intralesional Bevacizumab for Treating AIDS-associated Kaposi´s Sarcoma of the Larynx, Pharynx and Oral Cavity treatment 2 completed NCT00055237
Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients treatment 2 completed NCT00982449
124I-FIAU Imaging in EBV and KSHV Associated Cancers No drug interventions basic_science Not Available completed NCT01276236
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) treatment 2 completed NCT00006518
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer No drug interventions Not Available Not Available recruiting NCT00001535
Twins Study of Gene Therapy for HIV Infection treatment 1 completed NCT02212639
Phase II Multicentric Study of Digoxin Per os in Classic or Endemic Kaposi' s Sarcoma treatment 2 unknown_status NCT02029430
A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma treatment 2 completed NCT00339326
Risk Factors for Non-HIV-Related Kaposi s Sarcoma No drug interventions Not Available Not Available completed NCT00540566
Optical Biopsy of Human Skin in Conjunction With Laser Treatment No drug interventions Not Available Not Available completed NCT00287495
BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma treatment 1 terminated NCT04742387
Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis No drug interventions Not Available Not Available active_not_recruiting NCT04902443
Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV treatment 1 recruiting NCT04941274
Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma treatment 1 / 2 recruiting NCT06375122
Natural History Study of Kaposi Sarcoma No drug interventions Not Available Not Available recruiting NCT06445166
Propranolol for the Treatment of Kaposi Sarcoma in Adults treatment 2 not_yet_recruiting NCT00000987
A Study of Chemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDS treatment 1 completed NCT00000954
A Study of Chemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's Sarcoma treatment 1 completed NCT00002105
Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma treatment 3 completed NCT00002188
A Study of ALRT1057 in Patients With AIDS-Related Kaposi's Sarcoma treatment 2 completed NCT00000807
Phase II Evaluation of Low-Dose Oral Etoposide for the Treatment of Relapsed or Progressed AIDS-Related Kaposi's Sarcoma After Systemic Chemotherapy treatment 2 completed NCT00002318
A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma treatment 3 unknown_status NCT00002319
A Study of DOX-SL in the Treatment of AIDS-Related Kaposi's Sarcoma treatment 3 completed NCT02080416
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors treatment 0 terminated NCT00000725
A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma treatment 1 completed NCT02659930
Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma treatment 1 active_not_recruiting NCT00002366
The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma treatment 2 completed NCT03316274
Intra-lesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma treatment 0 completed NCT00001120
A Study of Patients With AIDS Syndrome No drug interventions Not Available Not Available completed NCT00002131
A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma treatment 2 completed NCT06480773
Kaposi Sarcoma Chemotherapy and Research (KS-CARE) No drug interventions Not Available Not Available not_yet_recruiting NCT00000660
Phase I Study of Weekly Oral VP-16 for AIDS-Associated Kaposi's Sarcoma treatment 1 completed NCT04305691
Trial of Ixazomib for Kaposi Sarcoma treatment 2 recruiting NCT00002262
A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma No drug interventions treatment 1 completed NCT00002189
Paclitaxel in Advanced Refractory Kaposi's Sarcoma (AIDS-KS): A Phase II Trial of Paclitaxel From Baker Norton Pharmaceuticals treatment 2 completed NCT05329792
L19IL2/L19TNF in Skin Cancer Patients treatment 2 recruiting NCT00002167
Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary. treatment 2 completed NCT03157167
An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) diagnostic 1 completed NCT00002212
A Study of Targretin Capsules in Patients With AIDS-Related Kaposi's Sarcoma treatment 2 completed NCT00000681
A Phase I Study of the Combination of Recombinant GM-CSF, AZT, and Chemotherapy (ABV) (Adriamycin, Bleomycin, Vincristine) in AIDS and Kaposi's Sarcoma treatment 1 completed NCT02229981
Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large B-cell Lymphoma or Kaposi Sarcoma treatment 1 / 2 withdrawn NCT05663502
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers No drug interventions Not Available Not Available recruiting NCT04028479
The Registry of Oncology Outcomes Associated With Testing and Treatment No drug interventions Not Available Not Available recruiting NCT00000687
Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma treatment 2 completed NCT03296553
Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial. treatment 2 completed NCT00002153
Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders treatment 1 completed NCT00002147
Use of Stealth Liposomal Doxorubicin HCl ( DOX-SL ) in the Treatment of Moderate to Severe AIDS-Related Kaposi's Sarcoma. treatment 3 completed NCT00002445
Safety and Effectiveness of an Experimental Drug, IM862, in Treating Kaposi's Sarcoma in AIDS Patients treatment 3 completed NCT01495598
Pomalidomide for Kaposi Sarcoma in People With or Without HIV treatment 1 / 2 completed NCT03404297
Compression Therapy for Leg Ulcers and Kaposi Sarcoma in Western Kenya No drug interventions treatment Not Available completed NCT00051597
A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies treatment 1 / 2 completed NCT03160183
Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi No drug interventions Not Available Not Available completed NCT02408861
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery treatment 1 recruiting NCT06004011
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW) No drug interventions screening Not Available recruiting NCT00002093
A Randomized Phase III Clinical Trial of Daunoxome Versus Combination Chemotherapy With Adriamycin/Bleomycin/Vincristine (ABV) in the Treatment of HIV-Associated Kaposi's Sarcoma. treatment 3 completed NCT00395278
Development of Serologic Assays for Human Herpes Virus-8 No drug interventions Not Available Not Available completed NCT03050788
Smartphone Confocal Microscopy for Diagnosing Kaposi's Sarcoma No drug interventions diagnostic Not Available completed NCT00002185
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 treatment 2 completed NCT01412515
A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma treatment 2 terminated NCT00002137
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Weekly x 4 No drug interventions treatment 1 completed NCT05411237
Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma treatment 3 not_yet_recruiting NCT04065152
Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi Sarcoma treatment 2 unknown_status NCT00001059
Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS treatment 2 completed NCT00002259
Phase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's Sarcoma treatment 2 completed NCT00002342
A Study of Tecogalan Sodium No drug interventions treatment 1 completed NCT03993106
A Study of sEphB4-HSA in Kaposi Sarcoma treatment 2 recruiting NCT00923936
Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma treatment 2 completed NCT00002136
A Phase I Trial of Tecogalan Sodium (DS-4152) Administered as an Infusion Every 21 Days No drug interventions treatment 1 completed NCT00001113
A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma treatment 1 completed NCT04893018
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV treatment 1 terminated NCT05081141
HHV8 and Solid Organ Transplantation No drug interventions Not Available Not Available recruiting NCT04303117
NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma treatment 1 / 2 recruiting NCT05846724
Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma treatment 2 not_yet_recruiting NCT00000996
A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma treatment 2 completed NCT00000763
A Phase I Study of TNP-470 in the Treatment of AIDS-Associated Kaposi's Sarcoma treatment 1 completed NCT00002439
A Study of ALRT 1057 Topical Gel in Patients With AIDS-Related Kaposi's Sarcoma treatment Not Available completed NCT00002226
Safety and Effectiveness of Giving SU5416 to HIV-Infected Patients With AIDS-Related Kaposi's Sarcoma treatment Not Available completed NCT02595866
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer treatment 1 completed NCT05859074
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer treatment 1 active_not_recruiting NCT00005931
SU5416 in Patients With AIDS-Related Kaposi's Sarcoma Who Have Not Responded to Treatment treatment 2 completed NCT00000694
A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma treatment 1 completed NCT05797662
A Study of Propranolol to Treat Kaposi Sarcoma treatment 2 not_yet_recruiting NCT03469804
Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma treatment 2 unknown_status NCT00000769
A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma treatment 1 completed NCT00006310
KSHV Infection in Blood Donors From Texas No drug interventions Not Available Not Available completed NCT00000695
Open Label Phase I Study To Evaluate the Safety of Combination Therapy With AZT and Interferon-Beta in Patients With AIDS Related Kaposi's Sarcoma treatment 1 completed NCT00001114
The Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's Sarcoma treatment 2 completed NCT00002314
A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma treatment 2 completed NCT00002138
A Phase I Trial of Tecogalan Sodium ( DS-4152 ) Administered as an Infusion Twice Weekly for 21 Days. No drug interventions treatment 1 completed